T大颗粒淋巴细胞白血病模型:如何模拟恶性自身免疫中的细胞间相互作用
本综述讨论T大颗粒淋巴细胞白血病(T-LGLL)的疾病模型,指出其常伴自身免疫病(尤其类风湿关节炎),共同分子机制涉及JAK/STAT信号激活、促炎细胞因子环境和抗原驱动免疫反应。现有小鼠模型各自仅模拟单一机制,无法完整再现克隆性T细胞扩增与复杂免疫失调的双重特征,作者提出克服现有模型不足的策略并强调需要更全面的新型模型。
要点
- T-LGLL以克隆性细胞毒性T细胞扩增为特征,血细胞减少不能用低白血病负荷解释。
- T-LGLL常伴自身免疫病尤其类风湿关节炎,共同机制包括JAK/STAT激活、促炎细胞因子和抗原驱动反应。
- 现有小鼠模型各自仅模拟单一机制,无法完整再现克隆性T细胞扩增与免疫失调的双重特征。
核心结论
- 作者认为需要能更忠实整合T-LGLL关键特征的新型全面模型,或通过体现疾病特定致病方面来补充现有不完整系统的模型。
- 作者期望此类新模型系统有助于更好理解肿瘤-免疫界面并评估T-LGLL的新治疗方法。
研究设计与样本
- 本文为综述,评估自体在体T-LGLL模型的标准并评价现有系统。
- 综述识别现有模型的优势、局限及其对LGLL临床病理方面的具体再现。
主要发现
- T-LGLL常伴自身免疫病尤其类风湿关节炎,克隆性T细胞扩增也越来越多地在自身免疫驱动状况中被识别。
- T-LGLL与自身免疫病的共同分子联系包括JAK/STAT信号激活、促炎细胞因子环境和抗原驱动免疫反应。
- 基于JAK/STAT的系统再现通路激活,细胞因子驱动模型模拟炎症条件,类风湿关节炎模型常模拟抗原刺激。
- 现有模型均未完全捕捉克隆性T细胞扩增与复杂免疫失调的双重性。
- 突出的转基因模型不仅操控T细胞区室,还非选择性地改变肿瘤微环境,妨碍对LGLL微环境成分具体作用的研究。
局限性
- 现有小鼠模型对机制的处理较为个体化,均未完全捕捉克隆性T细胞扩增与复杂免疫失调的双重性。
- 突出的转基因模型不仅操控T细胞区室,还非选择性地改变肿瘤微环境,妨碍对LGLL微环境成分具体作用的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
T-large granular lymphocytic leukemia (T-LGLL) is a chronic lymphoproliferative disorder characterized by clonal expansions of cytotoxic T-cells. It presents with cytopenias that are not explained by the typically low leukemic burden. Notably, T-LGLL is frequently accompanied by autoimmune disorders, particularly rheumatoid arthritis (RA). As clonal T-cell expansions are also increasingly identified in autoimmune-driven conditions, better models of T-LGLL's pathogenesis as a spectrum of (auto)antigen-driven oligoclonal hierarchies towards overt leukemic escape with associated immune dysregulations would provide details to a valuable prototype for determinants of T-cell fitness and transformation as well as T-cell instructed dysfunctions of other immune cells. Such insights would advance our concepts of cancer biology and immunology. Common molecular links between T-LGLL and autoimmune diseases include activation of JAK/STAT signaling, proinflammatory cytokine environments, and antigen-driven immune responses. Current murine models address these mechanisms rather individually: JAK/STAT based systems replicate pathway activation, cytokine-driven models simulate inflammatory conditions, and RA models often mimic antigen stimulation. However, none of these fully captures the duality of clonal T-cell expansion and the complex immune dysregulations, inherent to T-LGLL. This review examines criteria for autochthonous in-vivo T-LGLL models and evaluates existing systems, identifying their strengths, limitations, and specific representations of clinico-pathologic aspects of LGLL. Prominent transgenic models, for example, not only manipulate the T-cell compartment but also indiscriminately alter the tumor microenvironment, impeding research on the specific role of elements of the LGLL micromilieu. We propose strategies to overcome such insufficiencies of present models. Overall, our critical appraisal emphasizes the need for novel comprehensive models that more faithfully integrate the key features of T-LGLL or for models that, by featuring specific pathogenetic aspects of the disease, would supplement existing incomplete systems. We expect such new model systems to aid in better understanding the cancer-immunity interface and in assessing novel therapeutic approaches for T-LGLL.
引用
- Klepzig H, Herling M, Pflug N, et al. Models for T-large granular lymphocytic leukemia: how to mimic the cellular interplays in malignant autoimmunity. Leukemia. 2025. PMID: 40055531. doi:10.1038/s41375-025-02553-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。